Results 101 to 110 of about 3,875 (181)

MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia

open access: yes
Abstract Mutations in SET binding protein 1 ( SETBP1 ) are associated with an adverse prognosis in myeloid malignancies. These mutations stabilize SETBP1 protein, driving increased expression of a progenitor-associated gene expression program through incompletely described ...
Carlson, Hanqian L   +14 more
openaire   +3 more sources

SP29 | A RARE MYELOPROLIFERATIVE DISEASE: CHRONIC EOSINOPHILIC LEUKEMIA, NEW GENETIC FEATURES?

open access: yesHaematologica
Chronic Eosinophilic Leukemia (CEL) is a rare chronic myeloproliferative disease (MPN) characterized by a sustained clonal proliferation of eosinophilic precursor leading to persistent hypereosinophilia in blood, bone marrow and peripheral tissues.
M.P. Flagiello   +15 more
doaj  

Development of a human iPSC and patient phenotyping resource for preclinical investigations of neurodevelopmental disorders. [PDF]

open access: yesStem Cell Res
Chen C   +22 more
europepmc   +1 more source

Rare <i>NUP98::SETBP1</i> fusion transcript in a refractory adult T-cell lymphoblastic lymphoma. [PDF]

open access: yesAm J Cancer Res
Chen X   +9 more
europepmc   +1 more source

Gene expression of SETBP1 across GTEx tissues.

open access: yes
Ridgeline plot of the scaled median TPM values (x-axis) (A) across samples (denoted by bold number) for each GTEx tissue (y-axis) and (B) brain subregions (y-axis) for SETBP1 where disease-affected tissues are colored by dark purple and pink for true and
Amanda D. Clark (5257955)   +4 more
core   +1 more source

Predicting the clinical course of advanced systemic mastocytosis on treatment with avapritinib or midostaurin. [PDF]

open access: yesLeukemia
Lübke J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy